Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2

Antiviral Therapy

Volumn 3, Issue 4, 1998, Pages 209-214

  Stellbrink, Hans Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; NUCLEOSIDE ANALOG; RECOMBINANT INTERLEUKIN 2; SAQUINAVIR; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ARTICLE; AXILLARY LYMPH NODE; BLOOD ANALYSIS; CELL COUNT; CELL KINETICS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN SITU HYBRIDIZATION; INFECTION RATE; LATENT VIRUS INFECTION; LYMPH NODE BIOPSY; LYMPHOCYTE SUBPOPULATION; LYMPHOID TISSUE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; VIREMIA; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; KINETICS; LYMPHOID TISSUE; MALE; MIDDLE AGED; RNA, VIRAL; SAQUINAVIR; VIREMIA; ZALCITABINE; ZIDOVUDINE;

EID: 20644448203     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lafeuillade A, Poggi C, Tamalet C, Profizi N, Tourres C & Costes O. Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency-virus type 1 infection. Journal of Infections Diseases 1997; 175:1051-1055.
2. Notermans DW, De Wolf F, Foudraine NA, et al. The effects of an antiretroviral triple combination with ritonavir, AZT and 3TC. AIDS 1996; 10 (Suppl. 2):S17.
3. Cavert W, Notermans DW, Staskus K, Wietgrefe SW, Zupancic M, Gebhard K, Henry K, Zhang ZQ, Mills R, McDade H, Schuwirth CM, Goudsmit J, Danner SA & Haase AT. Kinetics of response in lymphoid tissue to antiretroviral therapy of HIV-1 infection. Science 1997; 276:960-964.
4. Tamalet C, Lafeuillade A, Fantini J, Poggi C & Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997; 11:895-901.
5. Stellbrink H-J, van Lunzen J, Hufert FT, Froschle G, Wolf-Vorbeck G, Zollner B, Albrecht H, Greten H, Racz P & Tenner-Racz K. Asymptomatic HIV infection is characterized by rapid turnover of HIV-RNA in plasma and lymph nodes but not of latently infected lymph node CD4+ T-cells. AIDS 1997; 11:1103-1110.
6. Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M & Ho DD. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997; 387:188-191.
7. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM & Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373:123-126.
8. Stellbrink HJ, Zöllner B, Fenner T, Lichtenberg G, van Lunzen J, Albrecht H, Thiele HG & Greten H. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection - evidence for an only transient interruption by treatment. AIDS 1996; 10:849-857.
9. Lafeuillade A, Poggi C, Tamalet C, Pellegrino P & Profizi N. Triple-drug combination in primary HIV-1 infection (PHI). AIDS 1996; 10:Abstract S31.
10. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J, Markowitz M, Ho DD, Richman DD & Siliciano RF. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-1300.
11. Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA & Richman DD. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291-1295.
12. Chun T-W, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA & Fauci AS. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proceedings of the National Academy of Sciences, USA 1997; 94:13193-13197.
13. + cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. Journal of Virology 1997; 71:8245-8253.
14. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, et al. Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. New England Journal of Medicine 1995; 332:567-575.
15. Mulder J, McKinney N & Kwok S. A rapid and simple sample preparation method dramatically increases sensitivity of HIV-1 plasma RNA assay. XIth International Conference on AIDS, 1996; Vancouver, Canada. Abstract Th.B.914.
16. Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, Raschdorff B, Grosschupff G, Steinman RM & Racz P. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T-cell counts are sites for virus replication and CD4 T-cell proliferation. The impact of highly active antiretroviral therapy. Journal of Experimental Medicine 1998; 187:949-959